Gregory Day

Has grant

Assistant Professor, Senior Associate Consultant

Mayo Clinic

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Gregory Day is an Assistant Professor and Senior Associate Consultant at Mayo Clinic in the United States. His research focuses on palliative care, autoimmune encephalitis, and cognitive dysfunction related to chronic kidney disease. Recent publications include studies on prion disease resource utilization, biomarkers of cerebral small vessel disease, and rapidly progressive dementia.

Recent Grants

Grant: Close

A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease

Open Date: 2021-09-01

Close Date: 2026-08-01

Grant: Close

LEADing Diverse Recruitment at Mayo Clinic

Open Date: 2021-06-01

Close Date: 2022-12-01

Grant: Close

Rapidly Progressive Dementia: Moving Beyond CJD

Open Date: 2019-08-01

Close Date: 2024-04-30

Grant: Close

Molecular mechanisms of the central regulator of TREM2 dysfunction

Open Date:

Close Date: 2022-11-01

Articles (23)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (13)

Anteneh Feyissa

Senior associate consultant/ Assistant Professor

Mayo Clinic Florida

UNITED STATES

View details

Albert Aboseif

Assistant Professor

Mayo Clinic

UNITED STATES

View details

Soon-Tae Lee

Professor

Seoul National University Hospital

SOUTH KOREA

View details

Kazushi Suzuki

The Univeristy of Tokyo

JAPAN

View details

Brian Appleby

Case Western Reserve University

UNITED STATES

View details

Sarah Berman

University of Pittsburgh

UNITED STATES

View details

louise mccullough

Professor and Chief of Neurology

The University of Texas Health Science Center at Houston John P and Katherine G McGovern Medical School

UNITED STATES

View details

Nick Corriveau-Lecavalier

Assistant Professor

Mayo Clinic

UNITED STATES

View details

Hongyu An

Professor

Washington University in Saint Louis School of Medicine

UNITED STATES

View details

James Torner

Iowa State University

UNITED STATES

View details

jingqin luo

Associate Professor

Washington University in Saint Louis School of Medicine

UNITED STATES

View details

S. Richard Dunham

UNITED STATES

View details

Charles Howe

Professor

Mayo Clinic

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gregory Day

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (23)

Cytokine, Chemokine, and Neurofilament Light Chain Signatures in LGI1 Autoimmune Encephalitis

The Neurologist's Role in Promoting Brain Health

A Phase-2B Double-Blind Randomized International Prospective Trial of Inebilizumab in NMDAR Encephalitis: The ExTINGUISH Trial

Palliative Care Resource Utilization in Patients With Prion Disease

MarkVCID2 Consortium for Clinical Validation of Biomarkers of Cerebral Small Vessel Disease: Validation Framework and Baseline Characteristics

The Clinical Trial Landscape in Autoimmune Encephalitis

Decoding the Clinical Features that Associate with Progression, Causes, and Outcomes in Patients with Suspected Rapidly Progressive Dementia

Uremic Toxins, CKD, and Cognitive Dysfunction

Longitudinal Evolution of Posterior Cortical Atrophy

Identification and diagnosis of ultra-rapid progressive dementia: evidence from a prospective cohort study and systematic literature review

Association of Resilience-Related Life Experiences on Variability on Age of Onset in Dominantly Inherited Alzheimer Disease

Disparate Dementia Risk Factors Are Associated with Cognitive Impairment and Rates of Decline in African Americans

Improving Early Recognition of Treatment‐Responsive Causes of Rapidly Progressive Dementia: The STAM3P Score

Incidence and risk factors associated with seizures in cerebral amyloid angiopathy

CWH43Variants Are Associated With Disease Risk and Clinical Phenotypic Measures in Patients With Normal Pressure Hydrocephalus

Association of Plasma Biomarkers of Alzheimer Disease With Cognition and Medical Comorbidities in a Biracial Cohort

Age-Specific Barriers and Facilitators to Research Participation Amongst African Americans in Observational Studies of Memory and Aging

Real‐time quaking‐induced conversion assays for prions: Applying a sensitive but imperfect test in clinical practice

Anti-amyloid therapies for Alzheimer disease: finally, good news for patients

Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study.

Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study.

Cross-sectional and longitudinal comparisons of biomarkers and cognition among asymptomatic middle-aged individuals with a parental history of either autosomal dominant or late-onset Alzheimer's disease

Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespan

Collaborators (13)

Anteneh Feyissa

Albert Aboseif

Soon-Tae Lee

Kazushi Suzuki

Brian Appleby

Sarah Berman

louise mccullough

Nick Corriveau-Lecavalier

Hongyu An

James Torner

jingqin luo

S. Richard Dunham

Charles Howe

Make your next move.